Beneficios cardiovasculares El estudio SUSTAIN-6 demostr que la semaglutida inyectable (Ozempic) reduce significativamente el riesgo de eventos cardiovasculares mayores en pacientes con diabetes tipo 2 y enfermedad cardiovascular establecida
More recent guidelines recommend screening for sarcopenic obesity, which is the loss of muscle despite higher body weight, especially in older adults (Spreckley 2026
GLP-1s can help with weight loss, but research shows that most Americans stop taking them within a year
Safety depends entirely on the specific peptide, its source, dosage, and the individual's clinical profile
Early exposure to germs modifies kidney damage and inflammation after experimental ischemia-reperfusion injury
If you want to know how to use glutathione patches to prevent and treat glutathione deficiency, its easy